Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Ribrag, Vincent, Dr, Koscielny, Serge, PhD, Bosq, Jacques, MD, Leguay, Thibaut, Casasnovas, Olivier, MD, Fornecker, Luc-Mathieu, Recher, Christian, Ghesquieres, Hervé, MD, Morschhauser, Franck, Prof, Girault, Stéphane, MD, Gouill, Steven Le, Prof, Ojeda-Uribe, Mario, MD, Mariette, Clara, MD, Cornillon, Jerome, MD, Cartron, Guillaume, Prof, Verge, Veronique, MD, Chassagne-Clément, Catherine, MD, Dombret, Hervé, Prof, Coiffier, Bertrand, Prof, Lamy, Thierry, Prof, Tilly, Hervé, Prof, Salles, Gilles, Prof
Published in The Lancet (British edition) (11.06.2016)
Published in The Lancet (British edition) (11.06.2016)
Get full text
Journal Article